Chemspace | Building Blocks for Analogs of Belumosudil

Warning!
Your browser does not support JavaScript or JavaScript support is disabled.
Display of the content may be incorrect. Please make sure that JavaScript is enabled in your browser. Warning!
Apparently you are using proxy server to access this site.
It means that display of the content may be incorrect.

Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.

Home News Building Blocks for Analogs of Belumosudil

28 July 2021

Building Blocks for Analogs of Belumosudil

This July, Belumosudil (REZUROCK) received approval by the FDA as the treatment of chronic graft versus host disease (cGvHD) in adults and children over 12. It is an orally available inhibitor of Rho-associated coiled-coil kinase 2 (ROCK 2) that binds to and inhibits the serine/threonine kinase activity of ROCK2.

Belumosudil contains quinazoline moiety in its backbone.

We have made a set of Building Blocks, which contain such parts – the perfect start for your research!

Building Blocks for Analogs of Belumosudil

Enquire for x () from in

Enquire for

Would you like to submit a custom request?

Enquiry for a list of compounds

Please select the ship to country:

Sign in